LipoCoat: Dutch biotech startup LipoCoat secures €1.5M to fight deadly hospital infections

More than half of the hospital infections are caused by the use of medical devices such as catheters and implants. Dutch biotech startup LipoCoat wants to fight these life-threatening bacterial infections in hospital environments and has now secured funding of €1.5 million amid coronavirus outbreak.